Compounds > lysyl-aspartyl-glutamyl-leucine
Page last updated: 2024-09-03

lysyl-aspartyl-glutamyl-leucine and recombinant soluble cd4

lysyl-aspartyl-glutamyl-leucine has been researched along with recombinant soluble cd4 in 1 studies

Compound Research Comparison

Studies
(lysyl-aspartyl-glutamyl-leucine)		Trials
(lysyl-aspartyl-glutamyl-leucine)		Recent Studies (post-2010)
(lysyl-aspartyl-glutamyl-leucine)		Studies
(recombinant soluble cd4)		Trials
(recombinant soluble cd4)		Recent Studies (post-2010) (recombinant soluble cd4)
12102261017

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boritz, E; Degar, S; Johnson, JE; Rose, JK1

Other Studies

1 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and recombinant soluble cd4

ArticleYear
Replication of primary HIV-1 isolates is inhibited in PM1 cells expressing sCD4-KDEL.
    Virology, 1996, Dec-15, Volume: 226, Issue:2

    Topics: CD4 Antigens; Cell Line; HIV-1; Humans; Oligopeptides; Protein Sorting Signals; Recombinant Proteins; Repetitive Sequences, Nucleic Acid; Virus Replication

1996